Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

January 02, 2007; 68 (1) In This Issue

January 2 Highlights

First published January 2, 2007, DOI: https://doi.org/10.1212/01.wnl.0000252797.07118.5c
Full PDF
Citation
January 2 Highlights
Neurology Jan 2007, 68 (1) 4-5; DOI: 10.1212/01.wnl.0000252797.07118.5c

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
336

Share

  • Article
  • Info & Disclosures
Loading

Abnormal cingulum fiber structure in MCI and AD


Embedded Image

Figure. Fractional anisotropy in the left posterior cingulum.

Using diffusion tensor imaging (DTI), Zhang et al. report structural alterations of cingulum fibers, which connect hippocampus and posterior cingulate gyrus, in subjects with mild cognitive impairment (MCI) and Alzheimer disease (AD). These alterations were better than conventional atrophy measurements in differentiating MCI and AD from normal aging.

see page 13

The editorial by Little and Holloway notes that although we can visualize and differentiate white and gray matter with standard MRI pulse sequences, they do not allow us to examine the integrity or directionality of white matter tracts. DTI takes advantage of the diffusivity of water and the restrictions imposed on the diffusion of water by white matter fiber tracts. In well-organized and intact white matter fiber tracts, water diffusion will occur preferentially along those tracts (i.e., be more anisotropic). When there is less organization or a lack of aligned and organized fiber structures (i.e., gray matter, CSF, axonal loss or demyelination), water diffusion will be more isotropic. The degree of alignment and anisotropy is commonly calculated as the fractional anisotropy. The exact reasons for the differences in water diffusion and mechanisms for underlying vulnerability of the white matter tracts are not yet fully understood in AD or in MCI, but could be related to ischemic changes, secondary axonal (wallerian) degeneration, or some type of primary white matter degeneration. DTI provides a method for identifying morphologic substrates or neuroanatomical correlates for disease progression. In addition, although investigations of underlying disease mechanisms will continue, the expression of these mechanisms on white matter fiber tracts (even if the mechanisms are not fully understood) provides fertile ground for prognostic and therapeutic research in vivo.

see page 9

Pilot study of coenzyme Q10 and GPI-1485 in PD

The NET-PD group's futility trial did not establish futility; this trial, their second pilot study, finds little to pursue for further investigation. The placebo group did better than expected and, when combined with other current studies, puts their prior results suggesting possible benefits of creatine and minocycline in a new perspective.

see page 20

Phenylbutyrate in spinal muscular atrophy

Mercuri et al. report a double-blind, randomized, placebo-controlled study in SMA type 2. The trial does not support the efficacy of phenylbutyrate at the regimen used in this study and highlights the need for placebo-controlled studies in SMA.

see page 51

The editorial by Kaufmann and Finkel notes that Mercuri et al. have confirmed that motor function assessments are feasible as the primary outcome in SMA trials. Although phenylbutyrate was not beneficial under the conditions of this study, a longer treatment period may be needed since rescuing neurons to measurably restore motor function may require an observation period beyond 13 weeks. Also, an alternative dosage or regimen might have been more effective. A phase 1 of phenylbutyrate study addressing some of the issues related to dose and regimen is under way in North America.

see page 11

Endurance training: A treatment for LGMD2I

Sveen et al. found that 12 weeks of moderate-intensity endurance training safely increased exercise performance in patients with limb-girdle muscular dystrophy type 2I (LGMD2I). The patients' maximal oxygen uptake and workload increased, muscle morphology and creatine kinase levels reflected no muscle damage, and self-reported questionnaires indicated better daily function after training.

see page 59

Vertebral artery hypoplasia and posterior stroke

Perren et al. studied 725 sequentially admitted first-ever stroke patients for vertebral artery hypoplasia. Vertebral artery hypoplasia was significantly more frequent in patients with posterior cerebral infarcts than in those with strokes in other vascular territories. Vertebral artery hypoplasia may be a predisposing factor in posterior circulation strokes.

see page 65

A 34-year-old man with progressive behavioral and language disturbance

In a new monthly feature, Neurology Clinical Pathological Conference, Dr. Bruce L. Miller discusses a case of a young man with a rapidly progressive cognitive and language impairment.

see page 68

View Abstract

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abnormal cingulum fiber structure in MCI and AD
    • Pilot study of coenzyme Q10 and GPI-1485 in PD
    • Phenylbutyrate in spinal muscular atrophy
    • Endurance training: A treatment for LGMD2I
    • Vertebral artery hypoplasia and posterior stroke
    • A 34-year-old man with progressive behavioral and language disturbance
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (2)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise